Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM.DL)

CAPS Rating: No stars

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:PPHM.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

ssanaka (< 20)
Submitted March 20, 2012

good product pipeline

AjarnMichael (64.58)
Submitted May 10, 2010

F

NASDAQ:PPHM.DL VS S&P 500 (SPY)

NASDAQ:PPHM.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about PPHM.DL.

No one has written a Pitch for PPHM.DL stock yet. Tell us why you think PPHM.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in PPHM.DL.

No players have picked PPHM.DL yet. Tell us why you think PPHM.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PPHM.DL.